Kronos Bio Presents Positive Preliminary Data from the Phase 1 Dose Escalation Portion of …

SAN MATEO, Calif. and CAMBRIDGE, Mass., Nov. 02, 2023 (GLOBE NEWSWIRE) — Kronos Bio, Inc. (Nasdaq: KRON), a company dedicated to transforming the …